Dr. Thomas A. Moore, MD
Infectious Disease (Infectious Disease Physician)
- Medicare participating
At a glance
- Medical school
- University of Kansas School of Med (Kc/Wich/Sal) (1989)
- Years since graduation
- 37
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 843
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1989Medical school: University of Kansas School of Med (Kc/Wich/Sal)
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Infectious Disease Physician primary
KS license 0423399
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Ascension Via Christi Hospitals Wichita, Inc. Wichita, KS
- Wesley Medical Center Wichita, KS
- Hutchinson Regional Medical Center Inc Hutchinson, KS
- Southwest Medical Center Liberal, KS
- Kansas Heart Hospital Wichita, KS
Medical groups
- Infectious Disease Consultants, P.a. (23 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 843
- Services billed
- 215,649
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Injection, daptomycin, 1 mg | 133,796 | 43 |
| Injection, dalbavancin, 5 mg | 11,400 | 11 |
| Injection, immune globulin (bivigam), 500 mg | 6,160 | 38 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 1,382 | 382 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 1,074 | 291 |
| Injection, ceftriaxone sodium, per 250 mg | 832 | 26 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 670 | 164 |
| Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | 630 | 11 |
| Injection, ertapenem sodium, 500 mg | 501 | 55 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 225 | 208 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Wichita, KS | 58 |
| Cephalexin Other prescribers in Wichita, KS | 43 |
| Metronidazole Other prescribers in Wichita, KS | 41 |
| Cefdinir Other prescribers in Wichita, KS | 38 |
| Daptomycin | 37 |
| Clindamycin Hcl Other prescribers in Wichita, KS | 36 |
| Ciprofloxacin Hcl Other prescribers in Wichita, KS | 35 |
| Doxycycline Hyclate Other prescribers in Wichita, KS | 24 |
| Penicillin V Potassium Other prescribers in Wichita, KS | 22 |
| Fluconazole Other prescribers in Wichita, KS | 20 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 12 payments worth $2,102 in total to this clinician.
| Aimmune Therapeutics, Inc. | $1,836 |
|---|---|
| AbbVie Inc. | $103 |
| Pfizer Inc. | $53.02 |
| Octapharma USA, Inc. | $45.68 |
| Csl Behring | $17.32 |
| Insmed, Inc. | $16.92 |
| Paratek Pharmaceuticals, Inc. | $15.24 |
| Melinta Therapeutics, LLC | $14.66 |
| Travel and Lodging | $936 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $900 |
| Food and Beverage | $266 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. Apr 3, 2025 | Travel and Lodging ZENPEP · ENDOCRINE PANCREATIC INSUFFICIENCY · travel to Tallahassee, FL · in-kind | $936 |
| Aimmune Therapeutics, Inc. Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) ZENPEP · ENDOCRINE PANCREATIC INSUFFICIENCY | $900 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.